Palo Alto Investors’s BioNTech BNTX Stock Holding History

Palo Alto Investors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Hold	19,614	–	–	0.25%	40
2026 Q1	$1.74M	Hold	19,614	–	–	0.27%	39
2025 Q4	$1.87M	Hold	19,614	–	–	0.26%	37
2025 Q3	$1.93M	Sell	19,614 -5,592	-22%	-$598K	0.36%	35
2025 Q2	$2.68M	Hold	25,206	–	–	0.57%	26
2025 Q1	$2.3M	Hold	25,206	–	–	0.44%	26
2024 Q4	$2.87M	Hold	25,206	–	–	0.45%	25
2024 Q3	$2.99M	Buy	+25,206	New	+$2.32M	0.39%	25

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Palo Alto Investors's BNTX Position: Q2 2026 in Review

Palo Alto Investors held its BioNTech (BNTX) position steady in Q2 2026 at 19,614 shares worth $1.83M. The position accounts for 0.25% of the portfolio, ranked #40.

Palo Alto Investors first reported a position in BNTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.99M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Palo Alto Investors held 19,614 shares of BioNTech worth $1.83M as of Q2 2026.
Palo Alto Investors left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.25% of Palo Alto Investors's portfolio in Q2 2026, its #40 holding.
Palo Alto Investors first reported a position in BioNTech in Q3 2024 and has held it in 8 quarters since.
Palo Alto Investors's BioNTech position peaked at $2.99M in Q3 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Palo Alto Investors's 13F filing for Q2 2026, filed 17 Aug 2026.